IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-22

Reporting Person: Underberg Sharon E. (SVP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-22	Common Stock	M	483	$206.94	Acquired	1878	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-22	Incentive Stock Option (right-to-buy)	$206.94	M	483	Disposed	2029-02-13	Common Stock (483)	Direct

Footnotes

F1: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020.

F2: Not applicable.